Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Center for International Blood and Marrow Transplant Research
City of Hope Medical Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Stanford University
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
University of Nebraska
West Virginia University
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
Medical College of Wisconsin
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Baylor College of Medicine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
University of Arizona
Columbia University
Columbia University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Barbara Ann Karmanos Cancer Institute
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center